208 related articles for article (PubMed ID: 32795883)
1. Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections.
Barocas JA; Gai MJ; Amuchi B; Jawa R; Linas BP
Drug Alcohol Depend; 2020 Oct; 215():108207. PubMed ID: 32795883
[TBL] [Abstract][Full Text] [Related]
2. Outcomes Associated With Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis.
Barocas JA; Morgan JR; Wang J; McLoone D; Wurcel A; Stein MD
Clin Infect Dis; 2021 Feb; 72(3):472-478. PubMed ID: 31960025
[TBL] [Abstract][Full Text] [Related]
3. Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use-Associated Infective Endocarditis.
Kimmel SD; Walley AY; Li Y; Linas BP; Lodi S; Bernson D; Weiss RD; Samet JH; Larochelle MR
JAMA Netw Open; 2020 Oct; 3(10):e2016228. PubMed ID: 33052402
[TBL] [Abstract][Full Text] [Related]
4. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18.
Jo Y; Nosal R; Vittori A; Cordova L; Vandever C; Alvarez C; Bartholomew TS; Tookes HE
Addiction; 2021 Aug; 116(8):2127-2134. PubMed ID: 33394516
[TBL] [Abstract][Full Text] [Related]
5. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
Mauro PM; Gutkind S; Annunziato EM; Samples H
JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
[TBL] [Abstract][Full Text] [Related]
6. Medications for opioid use disorder prescribed at hospital discharge associated with decreased opioid agonist dispensing in patients with opioid use disorder requiring critical care: A retrospective study.
Quaye A; Wampole C; Riker RR; Seder DB; Sauer WJ; Richard J; Craig W; Gagnon DJ
J Subst Use Addict Treat; 2023 Dec; 155():209176. PubMed ID: 37778703
[TBL] [Abstract][Full Text] [Related]
7. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Larochelle MR; Bernson D; Land T; Stopka TJ; Wang N; Xuan Z; Bagley SM; Liebschutz JM; Walley AY
Ann Intern Med; 2018 Aug; 169(3):137-145. PubMed ID: 29913516
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
Marks LR; Munigala S; Warren DK; Liss DB; Liang SY; Schwarz ES; Durkin MJ
J Infect Dis; 2020 Sep; 222(Suppl 5):S513-S520. PubMed ID: 32877547
[TBL] [Abstract][Full Text] [Related]
9. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting.
Morgan JR; Barocas JA; Murphy SM; Epstein RL; Stein MD; Schackman BR; Walley AY; Linas BP
JAMA Netw Open; 2020 Dec; 3(12):e2029676. PubMed ID: 33320266
[TBL] [Abstract][Full Text] [Related]
11. Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder.
Banta-Green CJ; Williams JR; Sears JM; Floyd AS; Tsui JI; Hoeft TJ
Drug Alcohol Depend; 2020 Feb; 207():107799. PubMed ID: 31865058
[TBL] [Abstract][Full Text] [Related]
12. Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults.
Welsh JW; Dennis ML; Funk R; Mataczynski MJ; Godley MD
J Subst Abuse Treat; 2022 Jan; 132():108584. PubMed ID: 34391589
[TBL] [Abstract][Full Text] [Related]
13. Medications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection.
Nolan NS; Marks LR; Liang SY; Durkin MJ
J Addict Med; 2021 Apr; 15(2):155-158. PubMed ID: 32804690
[TBL] [Abstract][Full Text] [Related]
14. Medications for opioid use disorder in pregnancy in a state women's prison facility.
Knittel AK; Zarnick S; Thorp JM; Amos E; Jones HE
Drug Alcohol Depend; 2020 Sep; 214():108159. PubMed ID: 32683223
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA
Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967
[TBL] [Abstract][Full Text] [Related]
16. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
[TBL] [Abstract][Full Text] [Related]
17. The cascade of care for opioid use disorder among youth in British Columbia, 2018.
Krebs E; Min JE; Zhou H; Davison C; McGowan G; Nosyk B
J Subst Abuse Treat; 2021 Nov; 130():108404. PubMed ID: 34118696
[TBL] [Abstract][Full Text] [Related]
18. The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder.
Friesen EL; Kurdyak P
Drug Alcohol Depend; 2020 Nov; 216():108244. PubMed ID: 32861134
[TBL] [Abstract][Full Text] [Related]
19. Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.
Cook RR; Jaworski EN; Hoffman KA; Waddell EN; Myers R; Korthuis PT; Vergara-Rodriguez P
Subst Abus; 2023 Oct; 44(4):301-312. PubMed ID: 37842910
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder.
Dowd WN; Barch DH; Seibert JH; Mark TL
J Subst Abuse Treat; 2022 Sep; 140():108824. PubMed ID: 35780730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
